Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.22.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net loss $ (20,948) $ (18,911)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 15,290 13,802
Stock-based compensation 8,533 7,205
Foreign currency transaction loss 2,792 4,181
Share in losses of associated companies 75 1,118
Revaluation of investments 1,061 (3,670)
Other non-cash items, net 83 193
Accounts receivable, net (7,950) 2,620
Inventories (14,775) 7,046
Other current assets and prepaid expenses 7,386 (3,775)
Other non-current assets (85) 1,595
Accounts payable 7,194 10,197
Other current liabilities (16,037) 6,453
Deferred revenues 2,522 (433)
Deferred income taxes, net and uncertain tax positions (381) (1,774)
Other non-current liabilities (823) (3,096)
Net cash provided by (used in) operating activities (16,063) 22,751
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (6,356)
Purchase of property and equipment (3,741) (4,012)
Investments in short-term bank deposits (40,000) (109,000)
Proceeds from short-term bank deposits 117,000 27,000
Purchase of intangible assets (444) (278)
Other investing activities (47) (98)
Investments in unconsolidated entities (5,030)
Net cash provided by (used in) investing activities 67,738 (92,744)
Cash flows from financing activities    
Proceeds from public offering, net of issuance costs 218,875
Proceeds from exercise of stock options 155 2,883
Other financing activities 866 407
Net cash provided by financing activities 1,021 222,165
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,228) (2,872)
Net change in cash, cash equivalents and restricted cash 50,468 149,300
Cash, cash equivalents and restricted cash, beginning of period 243,293 272,216
Cash, cash equivalents and restricted cash, end of period 293,761 421,516
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 188 884
Transfer of fixed assets to inventory 120 210
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 293,649 421,398
Restricted cash included in other current assets 112 118
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 293,761 $ 421,516